Skip to main content

Newsletter block in header

prev
next

Languages

You are here

COVID-19: What is MSF doing?

MSF teams are racing to respond to the COVID-19 pandemic in the more than 70 countries in which we run programmes, while opening projects in new countries as they become pandemic hotspots.

MSF’s COVID-19 response focuses on three main priorities: supporting health authorities to provide care for patients with COVID-19; protecting people who are vulnerable and at risk; and keeping essential medical services running.

Across our projects, MSF teams have been improving infection prevention and control measures to protect patients and staff and prevent further spread of the coronavirus.  It is absolutely crucial to protect health workers and patients both in COVID-19 care centres and in all other centres providing vital health services, to prevent health facilities from amplifying the pandemic or being forced to close their doors. 

Health systems worldwide are urgently in need of personal protective equipment (PPE) so that essential medical services can stay open.  The global shortage of PPE is indicative of the reality for health workers in most countries where we work, who face shortages of crucial items such as masks and aprons, and medical tools such as tests. Having access to protective equipment, to COVID-19 tests, to oxygen and to drugs for supportive care, becomes more and more urgent as COVID-19 spreads in countries with little access to these tools.

MORE ON OUR WORK ON COVID-19

17/06/2022

Inability to agree a real pandemic intellectual property Waiver at WTO is a devastating global failure for people the world over

MSF is disappointed in the inadequate outcome after nearly two years of discussions at the WTO.

06/06/2022

MSF to governments negotiating at WTO: get it right and adopt the real TRIPS Waiver

To effectively increase people’s access to all COVID medical tools, governments must return to TRIPS Waiver proposed over 20 months ago.

31/05/2022

German government must push BioNTech to urgently transfer mRNA vaccine technology

MSF urged the German government, which supported BioNTech’s vaccine research and development with hundreds of millions of euros in public funding, to push the corporation to urgently transfer mRNA vaccine technology to manufacturers in low- and middle-income countries.

04/04/2022

Neither the waiver people need nor a solution fit for a pandemic

Four reasons why we’re asking governments to reject the leaked text on COVID-19 at the WTO

COVID-19 vaccination line in Bugoye [© Théo  Wanteu/MSF ]
23/03/2022

Uganda: MSF helps vaccinate quarter of a million over-50s against COVID-19

MSF has been supporting the COVID-19 response in Kasese, Arua and Entebbe 

23/02/2022

Landmark ‘TRIPS Waiver’ must be agreed now: no time to lose

Access needs to be ensured for not just COVID-19 vaccines, but all COVID-19 medical tools, for everyone, everywhere.

18/02/2022

MSF responds to WHO announcement that 6 countries will receive tech from mRNA COVID-19 hub

The World Health Organization (WHO) has announced that Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia will be the first recipients of technology from the COVID-19 mRNA technology transfer hub.

A Sudanese health professional dresses in PPE during a training by MSF (March 2020)
14/12/2021

MSF is starting a COVID-19 intervention in Khartoum, Sudan

MSF is supporting existing isolation units to ensure the best use of existing capacities 

Pages

COVID-19: What is MSF doing?

MSF teams are racing to respond to the COVID-19 pandemic in the more than 70 countries in which we run programmes, while opening projects in new countries as they become pandemic hotspots.

MSF’s COVID-19 response focuses on three main priorities: supporting health authorities to provide care for patients with COVID-19; protecting people who are vulnerable and at risk; and keeping essential medical services running.

Across our projects, MSF teams have been improving infection prevention and control measures to protect patients and staff and prevent further spread of the coronavirus.  It is absolutely crucial to protect health workers and patients both in COVID-19 care centres and in all other centres providing vital health services, to prevent health facilities from amplifying the pandemic or being forced to close their doors. 

Health systems worldwide are urgently in need of personal protective equipment (PPE) so that essential medical services can stay open.  The global shortage of PPE is indicative of the reality for health workers in most countries where we work, who face shortages of crucial items such as masks and aprons, and medical tools such as tests. Having access to protective equipment, to COVID-19 tests, to oxygen and to drugs for supportive care, becomes more and more urgent as COVID-19 spreads in countries with little access to these tools.

MORE ON OUR WORK ON COVID-19